EX-23.1 4 w53555ex23-1.htm CONSENT OF KPMG LLP ex23-1

Consent of Independent Auditors

 

The Board of Directors
Guilford Pharmaceuticals Inc.:

We consent to the use of our report incorporated herein by reference.

/s/ KPMG LLP

Philadelphia, Pennsylvania
October 4, 2001